IDiyas

For the Inventor, By the Inventor

Mount Kisco, NY, United States of America

Aris I Baras

USPTO Granted Patents = 38 

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Mount Kisco, NY (US) (2018 - 2020)
  • Bedford Corners, NY (US) (2020 - 2022)
  • Tarrytown, NY (US) (2021 - 2024)

Company Filing History:

goldMedal36 out of 1,342 
 
Regeneron Pharmaceuticals, Inc.
 patents
silverMedal2 out of 293 
 
The Royal Institution for the Advancement of Learning/mcgill University
 patents
bronzeMedal1 out of 1 
 
Regeneron Phramaceuticals, Inc.
 patent
4. 1 out of 49 
 
Regeneran Pharmaceuticals, Inc.
 patents
5. 1 out of 2,007 
 
Duke University
 patents
where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...
Loading Chart...
38 patents (USPTO):Explore Patents
1. 12378557 - Treatment of sepsis with PCSK9 and LDLR modulators (2025-08-05),
2. 12370257 - Materials and methods of treating MHC-I-opathy risk haplotypes (2025-07-29),
3. 12359201 - 17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof (2025-07-15),
4. 12286677 - Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation (2025-04-29),
5. 12264366 - Genome-based methods for reducing cardiovascular risk (2025-04-01),
6. 12258627 - Kelch domain containing 7B (KLHDC7B) variants and uses thereof (2025-03-25),
7. 12234460 - Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors (2025-02-25),
8. 12215322 - Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors (2025-02-04),
9. 12186378 - Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists (2025-01-07),
10. 12163192 - Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof (2024-12-10),
11. 12157891 - Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors (2024-12-03),
12. 12123001 - Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors (2024-10-22),
13. 12070460 - Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors (2024-08-27),
14. 12018259 - Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors (2024-06-25),
15. 11957704 - Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors (2024-04-16),

Title: The Innovative Journey of Aris I Baras

Introduction: Aris I Baras, a talented inventor hailing from Mount Kisco, NY, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Aris I Baras holds several patents in the field of artificial intelligence and renewable energy technologies, showcasing his commitment to creating a sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Aris I Baras has led numerous successful projects that have revolutionized industries such as healthcare, transportation, and communication.

Collaborations: Throughout his career, Aris I Baras has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work in multidisciplinary teams has resulted in the development of cutting-edge solutions.

Conclusion: Aris I Baras continues to inspire the next generation of inventors with his innovative spirit and dedication to making the world a better place through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…